#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 12

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Trisomy 21

Recruiting

Investigational

Study of AEF0217 compared to placebo for improving behavior and thinking skills in adults and older adolescents with Down syndrome

Investigational

Italy

Participants:0–17 years · 18–64 years
Substances:1-((3S,8S,9S,10R,13S,14S,17S)3-BENZYLOXY-10,13,17-TRIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1HCYCLOPENTA[A]PHENANTHRENE-17-YL)ETHAN-1-ONE

Contact Research Centre

Diabetes mellitus

Recruiting

Investigational

A Study of Teplizumab Compared to Placebo for Blood Sugar Control in Children and Young Adults Aged 1 to 25 Years with Newly Diagnosed Type 1 Diabetes

Investigational

Italy

Participants:0–17 years · 18–64 years
Substances:Teplizumab

Contact Research Centre

Endometrial cancer metastatic

Recruiting

Registered drugNo placebo

A Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Azd8205

Contact Research Centre

Hypertrophic cardiomyopathy+1

Recruiting

Investigational

A study testing ninerafaxstat compared to placebo in patients with symptomatic non-obstructive hypertrophic cardiomyopathy

Investigational

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Atopic keratoconjunctivitis

Recruiting

Registered drug

A study testing DFL24498 eye drop solution to improve eye itching in adults with atopic keratoconjunctivitis

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S,34R)-30-Ethyl-34-[(E,2R)-Hex-4-En-2-Yl]-4,7,10,12,15,19,25,28-Octamethyl-33-(Methylamino)-6,9,18,24-Tetrakis(2-Methylpropyl)-3,21-Di(Propan-2-Yl)-1-Oxa-4,7,10,13,16,19,22,25,28,31-Decazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-Undecone Hydrochloride

Contact Research Centre

Breast cancer

Recruiting

InvestigationalNo placebo

A Study of BNT323 and BNT327 for Patients with Advanced Breast Cancer to Test Safety and Effectiveness

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:BNT327

Contact Research Centre

Narcolepsy

Recruiting

Investigational

A Study to Test the Safety and Effectiveness of TAK-360 in People with Narcolepsy without Cataplexy

Investigational

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Astrocytoma malignant

Recruiting

Investigational

Vorasidenib for patients with IDH-mutant grade 2 or 3 astrocytoma after completing first-line chemoradiotherapy

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Vorasidenib

Contact Research Centre

Renal cell carcinoma

Recruiting

Registered drugNo placebo

A Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Belzutifan

Contact Research Centre

Immune thrombocytopenia

Recruiting

InvestigationalNo placebo

A Follow-up Study of Mezagitamab in Adults with Chronic Primary Immune Thrombocytopenia to Evaluate Long-term Safety and Effectiveness

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Non-small cell lung cancer stage IV+2

Recruiting

Registered drug

A Study of BMS-986504 with Drug Combination Compared to Placebo with Drug Combination in Patients with Advanced Non-Small Cell Lung Cancer Starting First Treatment

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Chronic inflammatory demyelinating polyradiculoneuropathy

Recruiting

Investigational

A Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:IMEROPRUBART

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.